The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (87.19) USD. With the latest stock price at 0.33 USD, the upside of FibroGen Inc based on DCF is -26291.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.8% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (385.71) - (50.51) | (87.19) |
| Upside | -115964.1% - -15274.1% | -26291.2% |